![JCM | Free Full-Text | Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer JCM | Free Full-Text | Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer](https://www.mdpi.com/jcm/jcm-10-01436/article_deploy/html/images/jcm-10-01436-g001.png)
JCM | Free Full-Text | Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer
![CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer | Anticancer Research CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/38/1/465/F1.large.jpg)
CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer | Anticancer Research
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig3_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
![Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4244574818b6181db84800ea19173a80fa71094b/2-TableII-1.png)
Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar
![Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009898115003265-t2.jpg)
Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect
![Diagnostic accuracy of raised CA 15-3 and CEA tumour marker velocity... | Download Scientific Diagram Diagnostic accuracy of raised CA 15-3 and CEA tumour marker velocity... | Download Scientific Diagram](https://www.researchgate.net/publication/341513518/figure/tbl2/AS:893260222443520@1589981241230/Diagnostic-accuracy-of-raised-CA-15-3-and-CEA-tumour-marker-velocity-for-cancer-recurrence.png)
Diagnostic accuracy of raised CA 15-3 and CEA tumour marker velocity... | Download Scientific Diagram
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-gr3.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig1_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
![Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12282-020-01058-3/MediaObjects/12282_2020_1058_Fig3_HTML.png)
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
![The Use of Carbohydrate Antigen (CA) 15-3 as a Tumor Marker in Detecting Breast Cancer - SciAlert Responsive Version The Use of Carbohydrate Antigen (CA) 15-3 as a Tumor Marker in Detecting Breast Cancer - SciAlert Responsive Version](https://docsdrive.com/images/ansinet/pjbs/2008/tab1-2k8-5132.gif)
The Use of Carbohydrate Antigen (CA) 15-3 as a Tumor Marker in Detecting Breast Cancer - SciAlert Responsive Version
![Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase | British Journal of Cancer Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fbjc.2015.8/MediaObjects/41416_2015_Article_BFbjc20158_Fig1_HTML.jpg)
Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase | British Journal of Cancer
![Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-7549-g00.jpg)